GH1 and Hypercholesterolemia: The data of 12 patients aged ≥18 years (post-high school age) revealed the median height of −2.1 SD, the history of GH treatment in 54.5% of patients, IDDs in 16.7% of patients, NDDs in 25.0% of patients, a median BMI of 22.8, hypercholesterolemia in 63.6% of patients, and overt DM in 41.7% of patients [Supplementary Table S7 (6)].